Inhibitors of farnesyl protein transferase
CA 2239187 C · Owner: Leftheris, Katerina · Inventors: Kim, Soong-Hoon; Bhide, Rajeev; Mitt, Toomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This Invention relates to compounds that inhibit farnesyl-protein transferase and ras, protein farnesylation, thereby making them useful as anti-cancer agents. The compounds, are also useful 1n the treatment of diseases other than cancer, associated , with signal transduction pathways operating through ras and chose associated with proteins other than, ras that are also post-translationally modified by the enzyme farnesyl protein transferase. The compounds may also act as inhibitors of other prenyl transferases and , thus be effective, in the treatment of diseases associated with other prenyl modifications of proteins. The, compounds of the invention are of formulas I I I, I Il and IV.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 24, 1997 and granted April 22, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 24, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 24, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.